Treatment Patterns, Outcomes, And Patient Reported Health-Related Quality Of Life: A Prospective Disease Registry Of Patients With Mantle Cell Lymphoma Treated With Novel Agents
Principal Investigator(s)
Email for information
Funded by
HJF
Research Start Date
Status
Active
The primary objective of this study is to assess the treatment patterns, response rates, progression free survival and overall survival among patients diagnosed with MCL initiating novel therapies.
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.